Filing Flows › Bio Essence (BIOE) › Q1 2026 › vs Q1 2025
Bio Essence (BIOE) Q1 2026 vs Q1 2025 (year over year)
Bio Essence's revenue rose $478K (23×) from $22K in Q1 2025 to $501K in Q1 2026. Gross margin 63.8% against 92.8% (-29.0 pts).
Bio Essence, Q1 2026: revenue $501K (23× year over year), operating margin 43.1%, net earnings $205K, operating cash flow −$412K. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Gross margin | 63.8% | 92.8% | -29.0 pts |
| Operating margin | 43.1% | -924.3% | +967.4 pts |
| Net margin | 41.0% | -927.3% | +968.3 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $501K | $22K | $478K | 23× |
| Gross profit | $319K | $21K | $299K | 16× |
| Cost of revenue | $181K | $2K | $180K | 113× |
| Operating profit | $216K | −$205K | $421K | — |
| Operating expenses | $104K | $226K | −$122K | -54% |
| Pre-tax earnings | $215K | −$206K | $421K | — |
| Sales & marketing | $1K | $1K | $137 | +25% |
| General & admin | $103K | $225K | −$122K | -54% |
| Net earnings | $205K | −$206K | $411K | — |
| Income tax | $10K | $0 | $10K | — |
| Operating cash sources | $617K | −$180K | $797K | — |
| Depreciation & amortization | $59 | $59 | $0 | 0% |
| Cash used in operations | $412K | $26K | $386K | 16× |
| Working capital & other | $617K | −$180K | $797K | — |
Questions
How much did Bio Essence's revenue grow year over year in Q1 2026?
Bio Essence's revenue rose $478K (23×) from $22K in Q1 2025 to $501K in Q1 2026. Gross margin 63.8% against 92.8% (-29.0 pts).